Evidence map›Paper›PMID 30918945›Full record

ArticleInflammatory bowel diseases2019

Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells' Differentiation and Function in Induction of Colitis.

Liang Chen, Mingming Sun, Wei Wu, Wenjing Yang, Xiangsheng Huang, Yi Xiao, Chunyan Ma, Leiqi Xu, Suxia Yao, Zhanju Liu and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 208 citations in OpenAlex.

  1. Gut microbes · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Contextualizing TNature reviews. Immunology · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Liang ChenDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Mingming SunDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Wei WuDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Wenjing YangDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Xiangsheng HuangDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Yi XiaoDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Chunyan MaDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Leiqi XuDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Suxia YaoDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
Zhanju LiuDepartment of Gastroenterology, The Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Yingzi CongDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.
The University of Texas Medical Branch at Galveston · USTongji University · CN

Funding

Th17-IgA Axis in Regulation of Intestinal InflammationR01DK105585 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CONG, YINGZI · 2016 to 2020
$1.8M
The role of CBir1 flagellin-specific Th17 and Th1 effector cells in colitisR01DK079918 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CONG, YINGZI · 2008 to 2012
$1.5M
Microbiota metabolites, GPR, and inflammatory bowel diseasesR01DK112436 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CONG, YINGZI · 2017 to 2020
$1.4M
microRNA-10a Regulation of Inflammatory Bowel DiseasesR01DK098370 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CONG, YINGZI · 2013 to 2016
$1.3M
NIDDK NIH HHS R01 DK079918NIDDK NIH HHS R01 DK098370NIDDK NIH HHS R01 DK105585NIDDK NIH HHS R01 DK112436
6 · The paper itself

Abstract

backgroundHow the gut microbiota regulates intestinal homeostasis is not completely clear. Gut microbiota metabolite short-chain fatty acids (SCFAs) have been reported to regulate T-cell differentiation. However, the mechanisms underlying SCFA regulation of T-cell differentiation and function remain to be investigated.

methodsCBir1, an immunodominant microbiota antigen, transgenic T cells were treated with butyrate under various T-cell polarization conditions to investigate butyrate regulation of T-cell differentiation and the mechanism involved. Transfer of butyrate-treated CBir T cells into Rag1-/- mice was performed to study the in vivo role of such T cells in inducing colitis.

resultsAlthough butyrate promoted Th1 cell development by promoting IFN-γ and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Rorα, and Rorγt expression. Interestingly, butyrate upregulated IL-10 production in T cells both under Th1 and Th17 cell conditions. Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1. Rag1-/- mice transferred with butyrate-treated T cells demonstrated less severe colitis, compared with transfer of untreated T cells, and administration of anti-IL-10R antibody exacerbated colitis development in Rag-/- mice that had received butyrate-treated T cells. Mechanistically, the effects of butyrate on the development of Th1 cells was through inhibition of histone deacetylase but was independent of GPR43.

conclusionsThese data indicate that butyrate controls the capacity of T cells in the induction of colitis by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production, providing insights into butyrate as a potential therapeutic for the treatment of inflammatory bowel disease.

Indexed as

AnimalsButyratesCell DifferentiationColitisGastrointestinal MicrobiomeInterferon-gammaInterleukin-10Interleukin-17Intestinal MucosaMiceMice, Inbred C57BLMice, TransgenicNuclear Receptor Subfamily 1, Group F, Member 3T-bet Transcription FactorT-Box Domain ProteinsTh17 CellsButyratesIL10 protein, mouseInterferon-gammaInterleukin-10Interleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3T-bet Transcription FactorT-Box Domain ProteinsbutyratecolitisIL-10Th17 cellsTh1 cells

Identifiers

PMID30918945
PMCPMC6701512
OpenAlexW2925756170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.